|
Gene: SCN7A |
Gene summary for SCN7A |
Gene summary. |
Gene information | Species | Human | Gene symbol | SCN7A | Gene ID | 6332 |
Gene name | sodium voltage-gated channel alpha subunit 7 | |
Gene Alias | NaG | |
Cytomap | 2q24.3 | |
Gene Type | protein-coding | GO ID | GO:0001508 | UniProtAcc | Q01118 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6332 | SCN7A | P8T-E | Human | Esophagus | ESCC | 2.12e-03 | 2.57e-01 | 0.0889 |
6332 | SCN7A | P9T-E | Human | Esophagus | ESCC | 8.38e-03 | 1.36e-01 | 0.1131 |
6332 | SCN7A | P11T-E | Human | Esophagus | ESCC | 3.66e-11 | 8.26e-01 | 0.1426 |
6332 | SCN7A | P19T-E | Human | Esophagus | ESCC | 2.95e-08 | 1.09e+00 | 0.1662 |
Page: 1 |
Transcriptomic changes along malignancy continuum. |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ESCC: Esophageal squamous cell carcinoma | |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SCN7A | SNV | Missense_Mutation | c.1817N>C | p.Leu606Ser | p.L606S | Q01118 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | rs750200559 | c.626N>T | p.Arg209Ile | p.R209I | Q01118 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SCN7A | SNV | Missense_Mutation | c.2407N>T | p.Asp803Tyr | p.D803Y | Q01118 | protein_coding | deleterious(0) | probably_damaging(0.923) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
SCN7A | SNV | Missense_Mutation | c.2053N>A | p.Leu685Ile | p.L685I | Q01118 | protein_coding | deleterious(0.01) | benign(0.028) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
SCN7A | SNV | Missense_Mutation | c.845N>T | p.Arg282Ile | p.R282I | Q01118 | protein_coding | tolerated(0.15) | possibly_damaging(0.694) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
SCN7A | SNV | Missense_Mutation | c.944N>T | p.Gln315Leu | p.Q315L | Q01118 | protein_coding | tolerated(0.1) | benign(0.015) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SCN7A | SNV | Missense_Mutation | novel | c.3037N>A | p.Leu1013Ile | p.L1013I | Q01118 | protein_coding | tolerated(0.67) | benign(0.084) | TCGA-CK-4952-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SCN7A | SNV | Missense_Mutation | rs372024247 | c.4726G>A | p.Asp1576Asn | p.D1576N | Q01118 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-CM-6163-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SCN7A | SNV | Missense_Mutation | c.601N>G | p.Phe201Val | p.F201V | Q01118 | protein_coding | tolerated(0.19) | benign(0.138) | TCGA-DM-A1DA-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
SCN7A | SNV | Missense_Mutation | rs762095367 | c.882C>G | p.Asn294Lys | p.N294K | Q01118 | protein_coding | deleterious(0.04) | probably_damaging(0.949) | TCGA-F4-6805-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | xeloda | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL856 | PRIMIDONE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200440 | MEPIVACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL16 | PHENYTOIN | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1201020 | DISOPYRAMIDE PHOSPHATE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200464 | PROPARACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1255654 | TETRACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1200334 | MORICIZINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL1889140 | ROPIVACAINE HYDROCHLORIDE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL87992 | ESLICARBAZEPINE ACETATE | |
6332 | SCN7A | ION CHANNEL, DRUGGABLE GENOME | blocker | CHEMBL944 | CHLOROPROCAINE HYDROCHLORIDE |
Page: 1 2 3 4 5 6 |